Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Roflumilast in Non-CF Bronchiectasis
NCT04322929Phase 2Completed
- Sponsor
- The University of Hong Kong
- Start
- Nov 2020
- Primary completion
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of roflumilast in Non-cystic fibrosis bronchiectasis (NCFB), sponsored by The University of Hong Kong. Started Nov 2020; status: completed.
02
Drugs
roflumilast
03
Conditions
Non-cystic fibrosis bronchiectasis (NCFB)
Beyond the preview
Go deeper on NCT04322929.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04322929.